DistriMed Bioscience LLP

Established in 2017, Distrimed Bioscience (DBL) has emerged as a prominent figure in the pharmaceutical industry, specializing in the manufacture and export of a diverse range of products including Pharmaceutical Tablets, Capsules, Injections, Syrups, and Nutraceutical / Health Supplements. In 2024, the company further solidified its position by constructing a dedicated facility, featuring separate blocks for the manufacturing of pharmaceuticals and nutraceuticals / health supplements. Under the visionary leadership of Dr Janak Patel, Distrimed has assembled a team of highly skilled and enthusiastic individuals committed to making significant contributions to the healthcare sector. This collective effort has enabled DBL to develop an extensive product portfolio, establishing a strong presence in the market and attracting top-tier clientele. Operating from our WHO GMP certified plant; we at Distrimed uphold the highest standards of quality in manufacturing and exporting world-class products. Leveraging research-driven superior technology, robust infrastructure, and a commitment to continuous self-improvement, we consistently deliver excellence in our offerings. Distrimed is widely recognized as a dependable partner in the industry, catering to the manufacturing needs of a wide range of pharmaceutical products including Tablets, Capsules, Injections, Syrups, Dry Syrups (General and Beta Lactam), as well as Nutraceutical /Health Supplements such as Powders, Tablets, Sachet, Capsules, and Effervescent Products.